Human Stem Cells Institute PJSC Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2017
Human Stem Cells Institute PJSC reported unaudited consolidated earnings results for the first quarter ended March 31, 2017. For the quarter, total revenue was RUB 115,007,000 against RUB 93,644,000 a year ago. OIBDA loss was RUB 26,801,000 against OIBDA income of RUB 10,426,000 a year ago. Operating loss was RUB 36,665,000 against income of RUB 3,878,000 a year ago. Loss before income tax was RUB 29,216,000 against RUB 8,272,000 a year ago. Total comprehensive loss was RUB 29,498,000 against RUB 7,267,000 a year ago.